Selexis offers technology platform licensing opportunities within the biopharmaceutical industry for the use in R&D and commercial protein manufacturing. Standard evaluation periods range from 4 to 6 months. Under the evaluation contract, Selexis transfers detailed Standard Operating Procedures (SOPs) and provides consulting services. After a successful evaluation, Selexis and its Partner enter into an R&D or manufacturing license.
Contact Business Development for more information about Selexis' SURE Cell Line DevelopmentSM Services, partnerships, development capabilities or other opportunities, please contact :
North America
Selexis Inc.
197 Boston Post Road West
Suite 271
Marlborough, MA 01752
USA
T +1 508 485 9262
F +1 508 485 0609
e-mail: info@selexis.com
Offices:
55 New Montgomery St
Suite 605
San Francisco, CA 94105
USA
T +1 415 362 03 11
F +1 415 543 14 13
e-mail: info@selexis.com
find us on a map
Europe
Selexis SA
18 chemin des Aulx
1228 Plan-les-Ouates
Switzerland
T +41 (0)22 308 93 60
F +41 (0)22 308 93 61
e-mail: info@selexis.com
